Chart · view recorded under the Health care operations purpose
✦ AI Ask about this patient
✦ AI Start ambient note
✦ AI Draft instructions
Drafts awaiting signature
0
AI summary
drafted by claude-sonnet-5 from this record · verify against the chart
Catherina Lang is a 65-year-old woman with long-standing type 2 diabetes mellitus complicated by diabetic nephropathy and neuropathy, alongside metabolic syndrome, hypertension, and hyperlipidemia. She has had recent acute care contacts (ER admission, urgent care) with persistently elevated creatinine, suggesting worsening renal function. She remains on a stable regimen of statin, metformin, and antihypertensives.
Drives care
- Diabetic kidney disease (CKD stage 1) with rising creatinine
- Type 2 diabetes mellitus with neuropathy
- Essential hypertension and metabolic syndrome
- Hyperlipidemia/hypertriglyceridemia
Watch
- Creatinine trending upward (1.632 to 1.797 mg/dL) over past 2 months
- Recent ER admission (2026-01-03) - confirm cause and resolution
- No recent HbA1c or lipid panel data provided to assess diabetes/lipid control
Withheld from this view and from assistant retrieval:
1 × Reproductive health · 2 × Mental health.
Sensitive-category records exist and are counted, never silently absent — reaching
them takes the dedicated role and path, and every access is audited as a disclosure.
Your psychotherapy role can open the notes below.
Active problems
| Condition | Status | Onset |
|---|---|---|
| Chronic kidney disease stage 1 (disorder) | active | Sep 20, 2025 |
| Disorder of kidney due to diabetes mellitus (disorder) | active | Sep 20, 2025 |
| Neuropathy due to type 2 diabetes mellitus (disorder) | active | Dec 15, 2012 |
| Hyperglycemia (disorder) | active | Nov 22, 2008 |
| Sepsis (disorder) | active | Dec 17, 2007 |
| Anemia (disorder) | active | Nov 17, 2007 |
| Essential hypertension (disorder) | active | Nov 11, 2006 |
| Hypertriglyceridemia (disorder) | active | Nov 11, 2006 |
| Metabolic syndrome X (disorder) | active | Nov 6, 2004 |
| Diabetes mellitus type 2 (disorder) | active | Nov 6, 2004 |
| Hyperlipidemia (disorder) | active | Nov 2, 2002 |
| Body mass index 30+ - obesity (finding) | active | Nov 2, 2002 |
Active medications
| Medication | Dosage | Since |
|---|---|---|
| Simvastatin 10 MG Oral Tablet | — | Mar 1, 2026 |
| 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet | — | Feb 28, 2026 |
| amLODIPine 2.5 MG Oral Tablet | — | Feb 28, 2026 |
| lisinopril 10 MG Oral Tablet | — | Feb 28, 2026 |
| Chlorpheniramine Maleate 2 MG/ML Oral Solution | Take as needed. | Apr 29, 1966 |
Allergies
| Substance | Reaction | Verification |
|---|---|---|
| Allergic disposition (finding) | — | confirmed |
| Mold (organism) | — | confirmed |
| House dust mite (organism) | — | confirmed |
| Animal dander (substance) | Cough (finding) | confirmed |
| Grass pollen (substance) | — | confirmed |
| Tree pollen (substance) | — | confirmed |
| Cow's milk (substance) | — | confirmed |
| Tree nut (substance) | Wheal (finding) | confirmed |
Recent results
| Test | Value | When |
|---|---|---|
| HDL cholesterol | 70.39 mg/dL | Mar 1, 2026 |
| LDL cholesterol | 104.81 mg/dL | Mar 1, 2026 |
| Triglycerides | 199.86 mg/dL | Mar 1, 2026 |
| Total cholesterol | 200.84 mg/dL | Mar 1, 2026 |
| eGFR | 71.311 mL/min | Mar 1, 2026 |
| Potassium | 4.72 mmol/L | Mar 1, 2026 |
| Sodium | 136.31 mmol/L | Mar 1, 2026 |
| Glucose | 98.56 mg/dL | Mar 1, 2026 |
| eGFR | 81.62 mL/min/{1.73_m2} | Feb 28, 2026 |
| HDL cholesterol | 53.77 mg/dL | Feb 28, 2026 |
| LDL cholesterol | 53.05 mg/dL | Feb 28, 2026 |
| Triglycerides | 148.82 mg/dL | Feb 28, 2026 |
| Total cholesterol | 136.59 mg/dL | Feb 28, 2026 |
| Potassium | 3.8 mmol/L | Feb 28, 2026 |
| Sodium | 137.81 mmol/L | Feb 28, 2026 |
| Glucose | 93.38 mg/dL | Feb 28, 2026 |
| Respiratory rate | 15 /min | Feb 28, 2026 |
| Heart rate | 95 /min | Feb 28, 2026 |
| BMI | 28.79 kg/m2 | Feb 28, 2026 |
| Body weight | 81.4 kg | Feb 28, 2026 |
| Pain severity | 3 {score} | Feb 28, 2026 |
| Body height | 168.1 cm | Feb 28, 2026 |
| Hemoglobin A1c | 5.7 % | Feb 28, 2026 |
| eGFR | 107.31 mL/min/{1.73_m2} | Feb 28, 2026 |
| Creatinine abnormal | 1.797 mg/dL | Feb 28, 2026 |
| Hemoglobin A1c | 5.67 % | Jan 10, 2026 |
| eGFR | 96.026 mL/min/{1.73_m2} | Jan 10, 2026 |
| Creatinine abnormal | 1.731 mg/dL | Jan 10, 2026 |
| HDL cholesterol | 56.26 mg/dL | Jan 3, 2026 |
| LDL cholesterol | 104.23 mg/dL | Jan 3, 2026 |
Notes & documents
| Document | Author | Date | |
|---|---|---|---|
| No unrestricted documents. | |||
Claims
| Claim | Payer | Date | Status | Billed | Paid | |
|---|---|---|---|---|---|---|
| CLM-2026173001 | Cigna | Mar 1, 2026 | paid | $234.71 | $119.33 | Lines |
| CLM-2026173000 | Cigna | Mar 1, 2026 | paid | $41.08 | $0.00 | Lines |
| CLM-2026173005 | Cigna | Feb 28, 2026 | paid | $866.52 | $2,143.25 | Lines |
| CLM-2026173004 | Cigna | Feb 28, 2026 | paid | $36.76 | $0.00 | Lines |
| CLM-2026173003 | Cigna | Feb 28, 2026 | paid | $41.11 | $0.00 | Lines |
| CLM-2026173002 | Cigna | Feb 28, 2026 | paid | $31.73 | $0.00 | Lines |
| CLM-2026173006 | Cigna | Jan 17, 2026 | paid | $85.64 | $0.07 | Lines |
| CLM-2026173007 | Cigna | Jan 10, 2026 | paid | $36.41 | $0.00 | Lines |
Documentation drafts — this patient
No drafts for this patient yet. Ambient notes and AI-drafted documents land here, on the chart they belong to — and in the cross-patient Signature queue.
Imaging
| Study | Modality | Date | Series / images | |
|---|---|---|---|---|
| OP | May 13, 2016 | 1 / 2 | Open viewer |